Skip to main content
SpringerLink
Log in

Bevacizumab/gimeracil/oteracil/tegafur

Proteinuria in an elderly patient: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Yoshida M, et al. Retrospective study as first-line chemotherapy combined anti-VEGF antibody with fluoropyrimidine for frail patients with unresectable or metastatic colorectal cancer. Digestion 87: 59-64, No. 1, Jan 2013 - Japan

    Article  CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bevacizumab/gimeracil/oteracil/tegafur. Reactions Weekly 1488, 10 (2014). https://doi.org/10.1007/s40278-014-8774-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-8774-7

Search

Navigation